About Melissa McCracken
Melissa McCracken is a partner, nextech invest and director at Ambagon Therapeutics.
Melissa McCracken first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Melissa McCracken in the role, so the role may have started earlier or lasted longer.
Ambagon Therapeutics Inc.
Partner, Nextech Invest and director
2022 – 2025 · Eindhoven, Netherlands
Develops experimental cancer drugs that stabilize interactions between proteins.
Key Colleagues at Startups
The people Melissa McCracken works with at each company, as listed on that company's latest Form D.
Ambagon Therapeutics Inc. · Form D, Feb 7, 2025
JS
Josh Seidenfeld
Executive officer

Christian Ottmann
Co-Founder & Chief Executive Officer